EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Three injections of freeze‐dried platelet factor concentrate provide greater clinical response than single injection in the treatment of knee osteoarthritis

Tadahiko Ohtsuru iD, Hiroto Hanai, Taro Akimori, Wataru Ando, Norimasa Nakamura, Stephen Lyman iD

Journal of Experimental Orthopaedics · 2026-10 · 13 (4)

DOI: 10.1002/jeo2.70906 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Orthopaedics, online erschienen am 29.09.2026. Verfasst von Tadahiko Ohtsuru und 5 weiteren Autor:innen. Beteiligte Einrichtung: Omiya Knee Osteoarthritis Clinic Saitama Japan. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Single‐injection freeze‐dried platelet factor concentrate (PFC‐FD) has been shown to be safe and effective in the treatment of early knee osteoarthritis (OA) with clear advantages over other PRP processing methods. No previous clinical investigations have examined multiple PFC‐FD doses. The aim of this study was to assess the safety and effectiveness of one versus three PFC‐FD injections in patients with knee OA.

Methods

Patients with Kellgren–Lawrence (KL) Grade I–IV knee OA were prospectively recruited via shared decision‐making based on patient preference to receive either one ( n = 1054) or three ( n = 317) PFC‐FD injections. Patients completed a pre‐injection knee injury and OA outcomes survey (KOOS). Post‐injection, patients completed the KOOS at 1, 3, 6 and 12 months. Adverse events were documented. Response to treatment was assessed using the Outcome Measures in Rheumatology (OMERACT)‐Osteoarthritis Research Society International responder criteria. Multivariable modelling assessed treatment effectiveness, adjusting for patient differences.

Results

The three‐injection cohort demonstrated a small advantage in all KOOS subscales except quality of life (QOL) at 1 month (2.4–4.0 points, p < 0.0001–0.004), but this advantage disappeared by 3 months. When only early OA (KLI–II) was considered, the three‐injection cohort demonstrated higher improvement at 1, 3 and/or 6 months for most KOOS subscales. No such differences were observed for advanced OA patients. Multivariable analysis demonstrates that three‐injection patients were more likely to achieve responder status for KOOS‐Pain and KOOS‐activities of daily living (ADL) at 12 months (70.9% vs. 60.9%, p = 0.02 and 55.7% vs. 47.3%, p = 0.009, respectively). Overall patient‐level adverse events were higher in the three‐injection group (21.3% vs. 6.9%; p < 0.001), though adverse events per injection did not differ between groups (one‐injection 6.9%, three‐injection 8.6%; p = 0.19).

Conclusion

Based on non‐randomized allocation, a three‐injection PFC‐FD treatment protocol demonstrates a higher likelihood of clinical response compared to a one‐injection protocol, particularly for relief of early knee OA symptoms, without evidence of an adverse immune response. Level of Evidence Level II, prognostic prospective cohort study (patients enroled at different stages of disease progression).

Schlagwörter

Stichwörter der Autor:innen

biologic healing enhancementbone marrow aspirate concentrategrowth factorsplatelet‐rich plasmastem cell therapy

Autor:innen und Institutionen

  • Omiya Knee Osteoarthritis Clinic Saitama Japan.
  • Ohtsuru Orthopedic Clinic Shizuoka Japan.
  • Department of Orthopedic Surgery Tokyo Women's Medical University School of Medicine Tokyo Japan.
  • Department of Orthopedic Surgery, Graduate School of Medicine Osaka University Osaka Japan.
  • Institute for Medical Science in Sports Osaka Health Sciences University Osaka Japan.
  • Department of Medical Education Kyushu University School of Medicine Fukuoka City Japan.

ORCID-Profile: Tadahiko Ohtsuru, Stephen Lyman

Zitieren

APA

Ohtsuru, T., Hanai, H., Akimori, T., Ando, W., Nakamura, N., & Lyman, S. (2026). Three injections of freeze‐dried platelet factor concentrate provide greater clinical response than single injection in the treatment of knee osteoarthritis. Journal of Experimental Orthopaedics, 13(4). https://doi.org/10.1002/jeo2.70906

Vancouver

Ohtsuru T, Hanai H, Akimori T, Ando W, Nakamura N, Lyman S. Three injections of freeze‐dried platelet factor concentrate provide greater clinical response than single injection in the treatment of knee osteoarthritis. Journal of Experimental Orthopaedics. 2026;13(4). doi:10.1002/jeo2.70906

BibTeX
@article{Ohtsuru2026,
  author = {Ohtsuru, Tadahiko and Hanai, Hiroto and Akimori, Taro and Ando, Wataru and Nakamura, Norimasa and Lyman, Stephen},
  title = {Three injections of freeze‐dried platelet factor concentrate provide greater clinical response than single injection in the treatment of knee osteoarthritis},
  journal = {Journal of Experimental Orthopaedics},
  year = {2026},
  volume = {13},
  number = {4},
  doi = {10.1002/jeo2.70906}
}
Kostenlos starten →